Pandora Shares Rise as Q2 Results Beat Forecasts, 2026 Outlook Raised 
Tesla Roadster Reveal Could Feature SpaceX Thrusters in August 
LG, Nvidia Expand AI Partnership With Humanoid Robots, AI Factories 
Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says 
ANZ Home Loan Applications Drop 12% After Australia Property Tax Changes 
Apple Develops China-Specific AI Model With Alibaba as Apple Intelligence Launch Nears 
Cisco Forecasts Strong Fiscal 2027 Growth as AI Networking Demand Surges 
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth 
SMIC Shares Rally as Q2 Profit Surges 262% on Strong Chip Demand 
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan 
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal 
Bank of America to Buy Up to 49.9% Stake in Jio Credit for $1.92 Billion 
Stripe, Advent Reportedly Pursue $53 Billion PayPal Takeover 
Bernstein Picks BYD and Xiaomi as Top China EV Stocks Despite Weaker Demand 
Thyssenkrupp Raises 2026 Profit Outlook as Steel and Materials Units Strengthen 
Lenovo Revenue Surges 43% as AI Demand Drives Record First-Quarter Growth 
Antofagasta Shares Drop 5% as Miner Cuts 2026 Copper Production Forecast 
Add as a preferred source on Google
LOS ANGELES, June 12, 2017 -- Lundin Law PC , a shareholder rights law firm, announces a class action lawsuit against Lion Biotechnologies, Inc. (“Lion” or the “Company”) (Nasdaq:LBIO) for possible violations of federal securities laws between November 14, 2013 and April 10, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm by the June 13, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may choose to do nothing and be an absent class member as well.
The Complaint alleges that throughout the Class Period, Lion made false and/or misleading statements and/or failed to disclose: that the Company, through its former Chief Executive Officer (“CEO”) Manish Singh, engaged in a scheme to mislead investors by commissioning over 10 internet publications and 20 widely distributed emails promoting Lion to potential investors that purported to be independent from the company when they were actually paid promotions; that former CEO Singh engaged a notorious stock promotion firm to pay writers to publish articles about the Company on investment websites and to coordinate the distribution of articles to thousands of electronic mailboxes; that former CEO Singh actively participated in the promotional work for Lion and understood that the promotion firm was using writers who would not disclose that Lion was indirectly compensating them for their publications; and that as a result of the above, Lion’s public statements were materially false and misleading at all relevant times. Following this news, Lion’s stock price dropped materially, which caused investors harm according to the Complaint.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/
